Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$27,000.00

Duration of cochlear microphonics as a tool for classifying ANSD

FY 2024-25

Summary
Auditory neuropathy spectrum disorder (ANSD) impairs auditory nerve (AN) activity and accounts for about 10 percent of permanent hearing loss diagnoses. Detecting ANSD is a key component of newborn hearing screening programs and is done by identifying disrupted AN activity via auditory brainstem responses (ABR) and present otoacoustic emissions (OAEs);inner ear emissions that rule out other types of hearing loss such as sensory-only hearing loss (SHL). However, 25% of infants with ANSD have absent OAEs at the time of testing. These infants are at risk of delayed or incorrect diagnosis, leading to missed intervention opportunities. The cochlear microphonic (CM) is a measure detectable in infant ABRs and an additional diagnostic tool proposed to improve early detection of ANSD. CM duration may be longer in infants with ANSD due to the disruption in AN activity reducing negative feedback on the inner ear. We hypothesize that infants with ANSD will have longer CM durations than infants with SHL and typical hearing, and that infants with both ANSD and present or absent OAEs at the time of testing will have similar CM durations.To evaluate this, we will measure the CM duration from the ABRs of infants with ANSD, SHL, and typical hearing. Analyses of variances (ANOVAs) will evaluate the difference in CM duration between these groups. An ANOVA will also evaluate CM duration for infants with present and absent OAEs in addition to ANSD. We will set an a priori criteria of identifying 95% of the ANSD population (sensitivity) in order to assess the specificity of CM duration as a diagnostic tool for infants with ANSD. Findings could lead to improved sensitivity and specificity of ANSD diagnostic criteria, supporting earlier diagnosis and intervention for infants with ANSD.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
530370
Name
Fichter Chloe
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Duration of cochlear microphonics as a tool for classifying ANSD
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Auditory Brainstem Response; Auditory Neuropathy Spectrum Disorder; Cochlear Microphonic; Diagnosis; Hearing Loss; Infant; Otoacoustic Emissions; Sensitivity; Sensory Hearing Loss; Specificity
Abstract
Auditory neuropathy spectrum disorder (ANSD) impairs auditory nerve (AN) activity and accounts for about 10 percent of permanent hearing loss diagnoses. Detecting ANSD is a key component of newborn hearing screening programs and is done by identifying disrupted AN activity via auditory brainstem responses (ABR) and present otoacoustic emissions (OAEs);inner ear emissions that rule out other types of hearing loss such as sensory-only hearing loss (SHL). However, 25% of infants with ANSD have absent OAEs at the time of testing. These infants are at risk of delayed or incorrect diagnosis, leading to missed intervention opportunities. The cochlear microphonic (CM) is a measure detectable in infant ABRs and an additional diagnostic tool proposed to improve early detection of ANSD. CM duration may be longer in infants with ANSD due to the disruption in AN activity reducing negative feedback on the inner ear. We hypothesize that infants with ANSD will have longer CM durations than infants with SHL and typical hearing, and that infants with both ANSD and present or absent OAEs at the time of testing will have similar CM durations.To evaluate this, we will measure the CM duration from the ABRs of infants with ANSD, SHL, and typical hearing. Analyses of variances (ANOVAs) will evaluate the difference in CM duration between these groups. An ANOVA will also evaluate CM duration for infants with present and absent OAEs in addition to ANSD. We will set an a priori criteria of identifying 95% of the ANSD population (sensitivity) in order to assess the specificity of CM duration as a diagnostic tool for infants with ANSD. Findings could lead to improved sensitivity and specificity of ANSD diagnostic criteria, supporting earlier diagnosis and intervention for infants with ANSD.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fichter, Chloe
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~